DE69021007T2 - Maltodextrin-Entschäumungszusammensetzung. - Google Patents

Maltodextrin-Entschäumungszusammensetzung.

Info

Publication number
DE69021007T2
DE69021007T2 DE69021007T DE69021007T DE69021007T2 DE 69021007 T2 DE69021007 T2 DE 69021007T2 DE 69021007 T DE69021007 T DE 69021007T DE 69021007 T DE69021007 T DE 69021007T DE 69021007 T2 DE69021007 T2 DE 69021007T2
Authority
DE
Germany
Prior art keywords
defoaming
maltodextrin
weight percent
composition
defoaming composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69021007T
Other languages
English (en)
Other versions
DE69021007D1 (de
Inventor
William Valentine
William K Valentine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Technology Pharmaceuticals Corp
Original Assignee
Valentine Enterprises Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentine Enterprises Inc filed Critical Valentine Enterprises Inc
Publication of DE69021007D1 publication Critical patent/DE69021007D1/de
Application granted granted Critical
Publication of DE69021007T2 publication Critical patent/DE69021007T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Degasification And Air Bubble Elimination (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DE69021007T 1989-10-19 1990-10-10 Maltodextrin-Entschäumungszusammensetzung. Expired - Fee Related DE69021007T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/423,877 US5073384A (en) 1989-10-19 1989-10-19 Maltodextrin/defoaming composition combinate

Publications (2)

Publication Number Publication Date
DE69021007D1 DE69021007D1 (de) 1995-08-24
DE69021007T2 true DE69021007T2 (de) 1996-03-21

Family

ID=23680536

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69021007T Expired - Fee Related DE69021007T2 (de) 1989-10-19 1990-10-10 Maltodextrin-Entschäumungszusammensetzung.

Country Status (6)

Country Link
US (1) US5073384A (de)
EP (1) EP0425450B1 (de)
JP (1) JPH0815521B2 (de)
AT (1) ATE125170T1 (de)
CA (1) CA2026030C (de)
DE (1) DE69021007T2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
DE4140116A1 (de) * 1991-12-05 1993-06-09 Bolder Arzneimittel Gmbh Dimeticon-pastillen
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
CA2177476A1 (en) * 1993-11-30 1995-06-08 Maryellen L. Giger Automated method and system for the alignment and correlation of images from two different modalities
WO1996004128A1 (de) * 1994-08-03 1996-02-15 Voss Gunter M Verfahren zur herstellung von manteltabletten
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
GB9523136D0 (en) * 1995-11-11 1996-01-10 Procter & Gamble Silicone-containing powders
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
JP3001440B2 (ja) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 仮想ｌａｎ方式
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
JP2002523358A (ja) * 1998-08-25 2002-07-30 プラット，クリス ナプロキセンおよびプソイドエフェドリンを含む徐法性錠剤
FR2803720B1 (fr) 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6399591B1 (en) 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
EP1256347A1 (de) * 2001-05-10 2002-11-13 Swiss Caps Rechte und Lizenzen AG Verwendung von Stärke zur Herstellung eines Mittels für eine therapeutische Behandlung
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
EP2363428B1 (de) * 2010-02-23 2014-03-05 Dow Global Technologies LLC Rheologiemodifizierer für Zementschlämme
CN101804199B (zh) * 2010-03-30 2012-07-25 四川健能制药有限公司 一种用于消化道的药物组合物及其应用
GB201014041D0 (en) 2010-08-23 2010-10-06 Biofilm Ltd Soluble film
MX2013004095A (es) 2010-12-10 2013-07-17 Dow Corning Composicion granulada antiespuma.
GB201021170D0 (en) 2010-12-10 2011-01-26 Dow Corning Granulated organopolysiloxane products
JP2013103204A (ja) * 2011-11-16 2013-05-30 Shin-Etsu Chemical Co Ltd 粉末消泡剤及びその製造方法
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
MX368363B (es) 2012-06-12 2019-09-30 Procter & Gamble Forma de dosificacion efervescente.
JP6026859B2 (ja) * 2012-11-16 2016-11-16 楠本化成株式会社 水性塗料用消泡剤の消泡性改良剤
JP5969360B2 (ja) * 2012-11-19 2016-08-17 楠本化成株式会社 揮発分のない水性塗料用消泡剤
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
MX2016016587A (es) * 2016-12-14 2018-06-13 Rhein Siegfried Sa De Cv Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.
US20230248026A1 (en) 2020-07-03 2023-08-10 Arla Foods Amba Neutral instant beverage whey protein powder
CN112044119A (zh) * 2020-09-07 2020-12-08 安徽銮威化工科技开发有限公司 一种pvc用有机硅消泡剂及其制备方法
CN112263851A (zh) * 2020-09-30 2021-01-26 四川健能制药有限公司 一种二甲硅油消泡组合物的制备方法
WO2023089432A1 (en) 2021-11-16 2023-05-25 Johnson & Johnson Consumer Inc. Customizable dosage forms containing simethicone

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA508856A (en) * 1955-01-04 Shell Development Company Non-foaming detergents
US2441098A (en) * 1946-09-09 1948-05-04 Corning Glass Works Methyl siloxane polymers and method of preparation
US2774710A (en) * 1952-12-15 1956-12-18 Organon Pharmaceutical preparation for the treatment of hyperacidity
CA662734A (en) * 1959-07-20 1963-05-07 Hercules Powder Company Defoamer
US3207698A (en) * 1963-02-13 1965-09-21 Nopco Chem Co Composition and method for defoaming aqueous systems
US3304266A (en) * 1963-05-06 1967-02-14 Dow Corning Foam control agents
US3388073A (en) * 1963-12-16 1968-06-11 Nalco Chemical Co Process of defoaming and inhibiting foam formation in aqueous systems
US3326754A (en) * 1965-06-10 1967-06-20 Rexall Drug Chemical Method of relieving gastrointestinal distress with tributyl phosphate
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3849194A (en) * 1966-12-19 1974-11-19 Cpc International Inc Low d.e. starch conversion products
USRE30880E (en) * 1967-03-24 1982-03-09 Grain Processing Corporation Low D.E. starch conversion products
US3528929A (en) * 1967-05-24 1970-09-15 Buckman Labor Inc Defoaming,deaerating,and drainage aid compositions
US3663369A (en) * 1968-02-23 1972-05-16 Grain Processing Corp Hydrolysis of starch
DE1914684B2 (de) * 1969-03-22 1975-12-04 Th. Goldschmidt Ag, 4300 Essen Entschäumeremulsion
DE1936126C3 (de) * 1969-07-16 1973-12-06 Bayer Ag, 5090 Leverkusen Entschäumer
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
US3909445A (en) * 1970-03-18 1975-09-30 Mobil Oil Corp Method for reducing foam in water containing systems
US3714068A (en) * 1970-12-28 1973-01-30 Philadelphia Quartz Co Silica
US3705859A (en) * 1970-12-30 1972-12-12 Hercules Inc Method of abating foam formation in aqueous systems
US4298400A (en) * 1971-01-18 1981-11-03 Grain Processing Corporation Low D.E. starch conversion products
GB1378874A (en) * 1971-07-01 1974-12-27 Dow Corning Ltd Foam control substance
BE788249A (fr) * 1972-05-15 1973-02-28 Dow Corning Compositions de silicones pour lutter contre le moussage dans les procedes de teinture au jet
US3784479A (en) * 1972-05-15 1974-01-08 Dow Corning Foam control composition
US4102823A (en) * 1972-12-08 1978-07-25 The Procter & Gamble Company Low and non-phosphate detergent compositions
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
US3912652A (en) * 1973-12-17 1975-10-14 Dow Corning Defoaming composition useful in jet dyeing
US3959176A (en) * 1974-09-09 1976-05-25 Drew Chemical Corporation Non-foaming dispersing composition
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4230693A (en) * 1975-04-21 1980-10-28 Armour-Dial, Inc. Antacid tablets and processes for their preparation
US4180485A (en) * 1977-11-02 1979-12-25 The Procter & Gamble Company Spray-dried detergent compositions
CH636123A5 (de) * 1978-06-07 1983-05-13 Ciba Geigy Ag Verfahren zur herstellung schaumregulierter waschmittel.
US4386106A (en) * 1981-12-01 1983-05-31 Borden, Inc. Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4698264A (en) * 1982-08-02 1987-10-06 Durkee Industrial Foods, Corp. Particulate composition and process for making same
US4514319A (en) * 1983-03-25 1985-04-30 Union Carbide Corporation Antifoam composition containing hydrocarbon-silicon copolymer, hydrophobic filler and hydrocarbon oil
US4497832A (en) * 1983-04-18 1985-02-05 Warner-Lambert Company Chewing gum composition having enhanced flavor-sweetness
JPS59222209A (ja) * 1983-05-30 1984-12-13 Shin Etsu Chem Co Ltd 固形消泡剤
US4581381A (en) * 1983-11-14 1986-04-08 Nabisco Brands, Inc. Soft homogeneous antacid tablet
JPS6142309A (ja) * 1984-08-06 1986-02-28 Shin Etsu Chem Co Ltd 粉末消泡剤
US4590075A (en) * 1984-08-27 1986-05-20 Warner-Lambert Company Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8521956D0 (en) * 1985-09-04 1985-10-09 Unilever Plc Antifoam ingredient
US5004595A (en) * 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US4804543A (en) * 1987-07-14 1989-02-14 Warner-Lambert Company Novel hydrophilic plasticizing system and chewing gum containing same
US5024937A (en) * 1989-04-06 1991-06-18 Dow Corning Corporation Method for processing aqueous fermentation broths

Also Published As

Publication number Publication date
ATE125170T1 (de) 1995-08-15
JPH03151005A (ja) 1991-06-27
CA2026030C (en) 1997-04-01
DE69021007D1 (de) 1995-08-24
US5073384A (en) 1991-12-17
EP0425450A2 (de) 1991-05-02
EP0425450B1 (de) 1995-07-19
EP0425450A3 (de) 1991-07-10
JPH0815521B2 (ja) 1996-02-21
CA2026030A1 (en) 1991-04-20

Similar Documents

Publication Publication Date Title
ATE125170T1 (de) Maltodextrin-entschäumungszusammensetzung.
ATE319435T1 (de) Entschäumende zusammensetzung
HK1014186A1 (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ES2159524T3 (es) Preparacion farmaceutica para administrarse en el interior de las vias respiratorias.
ATE119766T1 (de) Zubereitung für den magen.
FR2643233B1 (fr) Composition absorbant l'oxygene, procede pour sa formulation et sachet la contenant
CA2149362A1 (en) Pharmaceutical composition based on guar gum coated with simethicone, inassociation with a neutralizing antacid
NO160330C (no) Anordning for aa administrere medikamenter til pasienter og medikamentpakning for anordningen.
DE3674444D1 (de) Optisch aktive verbindungen, sie enthaltende smektische fluessigkristalline zusammensetzungen und smektische fluessigkristallanzeigevorrichtungen.
ATE271387T1 (de) Arzneizubereitungen enthaltend vitamin d und kalzium,ihre herstellung und therapeutische verwendung
NZ337418A (en) Paracetamol composition with improved rate of absorption
EP0418597A3 (en) Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
SE8400723D0 (sv) Farmaceutisk komposition
CA2046533A1 (en) Treatment of endometriosis
DE69224836D1 (de) Optisch aktive tetrahydropyran derivate, flüssigkristallzusammensetzungen und diese enthaltende flüssigkristallelemente
SE7900774L (sv) Stabilsteril vattenlosning av cisplatin
ATE93136T1 (de) Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form.
DE69414622D1 (de) Streptogramine in gereinigte Form, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
KR870010082A (ko) 구아르(guar) 분말
FI952765A (fi) Desogestreeliä sisältävä tabletti, kapseli tai rae
KR910004181A (ko) 생체내 유효성을 증가시키는 신규의 제약학적 경구 투여 형태
BR9802490A (pt) Sistema de destilação criogênica de gás, e, processo para produzir argónio substancialmente livre de nitrogênio
JPS55153717A (en) Preparation of ubidecarenone soft capsule
FR2522966B1 (fr) Comprime en forme de gelule, procede et dispositif pour sa preparation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ADVANCED TECHNOLOGY PHARMACEUTICALS CORP., DACULA,

8339 Ceased/non-payment of the annual fee